WELCOME TO The HEALTHCARE REPORT
Newsletter | Member Login | Signup
Home > Companies > Emergency Service Partners, L.P.
Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...
Health Technology
Perimeter Medical Imaging AI, Inc. | September 30, 2022
Perimeter Medical Imaging AI, Inc. announced the commercial placement of its flagship Perimeter S-Series OCT system at a hospital that is part of a major national healthcare system and one of the largest healthcare networks in North Texas. Perimeter is a medical technology company driven to transform cancer surgery with ultra-high-resolution, real-time, advanced imaging tools to address high unmet medical needs. “This commercial placement of our Perimeter...
One Touch Telehealth | November 11, 2020
One Touch Telehealth reports its new programming discharge, Version 5.0: "Beyond Virtual Care." Carrie Chitsey, Co-Founder and CEO says that, "With the expansion in video telehealth in the midst of COVID-19, virtual care is setting down deep roots. We optimized our new delivery given the 500%+ expansion in the utilization of video telehealth from our customer base and bits of knowledge from our clients on...
Health Technology, Digital Healthcare
Memora Health and Perigen | January 09, 2023
Memora Health, one of the leaders in virtual care delivery and managing complex care, teamed up with PeriGen, a pioneer in using AI to make childbirth safer. Memora Health, which has the finest intelligent platform for virtual care delivery and managing complex care, announced a partnership with PeriGen, the market leader in using artificial intelligence (AI) to make childbirth safer. It is the first partnership of its kind, which aims to give health systems a chance to use cuttin...
Future of Healthcare
Medicago | May 06, 2022
Medicago announced the publication of the results from the Phase 3 study of COVIFENZ®, COVID-19 vaccine recombinant, adjuvanted, in the New England Journal of Medicine. The Phase 3 trial studied the two-dose regimen of COVIFENZ® given 21 days apart versus placebo in over 24,000 subjects aged 18 and above. Common side effects in the vaccine group included injection site pain, headache, fatigue, fever, muscle aches, and chills. COVIFENZ® is indicated for active immunizatio...
infographic
Video
Whitepaper
Keep me plugged in with the best
Join thousands of your peers and receive our weekly newsletter with the latest news, industry events, customer insights, and market intelligence.
Welcome back!
Put your news, events, company, and promotional content in front of thousands of your peers and potential customers.
Not a member yet? Not a problem, Sign Up
Sign up
Sign up to contribute and publish your news, events, brand, and content with the community for FREE